An Australian tech entrepreneur has helped create what appears to be a made-to-measure cancer vaccine for his dog, Rosie ...

One man moved heaven and earth and AI to cure his dog’s cancer, but far from a one-in-a-million miracle, this could become a ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB0) (OTCQB: BVAXF) ("BioVaxys") and Adiverna LLC ("Adiverna") announce today that they have entered into a Research Agreement ...

Scientists developed a new mRNA platform that keeps vaccines and therapies effective in older adults and patients with obesity, where current treatments often lose potency. (Nanowerk News) Researchers ...

One dog, one vaccine, one data point. The story of Rosie is fascinating – but it is not yet evidence that AI can beat cancer.

"The vaccine pushed back about 75 percent of the cancer," the dog owner, tech entrepreneur Paul Conyngham, said.

Next Conyngham used Grok to design an mRNA vaccine that boosts the production of tumor-associated antigens enabling Rosie's ...

Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...

AI-driven tumor immunity mapping could improve mRNA vaccine design, delivery, and personalization in oncology. Read more.

Pioneering clinical trial testing how personalised mRNA vaccines can enable the immune system to target recurring pancreatic ...

With no biology degree and just $3,000, he designed a personalized mRNA vaccine in a world first. Moderna and Merck are ...